Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The CX3C chemokine fractalkine (CX3CL1) exists as both a membrane‐bound form promoting firm cell‐cell adhesion and a soluble form chemoattracting leukocytes expressing its receptor CX3CR1. When adenoviral vector expressing mouse fractalkine (AdFKN) was transduced to the tumor cells, fractalkine was expressed as both membrane‐bound form on the tumor cells and soluble form in the supernatant in vitro. Intratumoral injection of AdFKN (1×10 9 PFU/tumor) into C26 and B16F10 tumors resulted in marked reduction of tumor growth compared to control (C26: 86.5%, p<0.001; B16F10: 85.5%, p<0.001). Histological examination of tumor tissues revealed abundant infiltration of NK cells, dendritic cells, and CD8+ T lymphocytes 3 and/or 6 days after treatment with AdFKN. Splenocytes from mice treated by AdFKN developed tumor‐specific cytotoxic T cells, and thereby protected from rechallenging with parental tumor cells. Antitumor effects by AdFKN were completely abrogated in both NK cell‐depleted mice and CD8–/– mice, and partially blocked in CD4–/– mice. These data indicated that fractalkine mediates antitumor effects by both NK cell‐dependent and T cell‐dependent mechanisms. This study suggests that fractalkine can be a suitable candidate for immunogene therapy of cancer because fractalkine induces both innate and adaptive immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.
Carr, M. W., Roth, S. J., Luther, E., Rose, S. S., & Springer, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3652 · Cited by 1,198
Dendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity
Zitvogel, L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012040 · Cited by 268
Cited by
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Wendel, M., Galani, I. E., Suri-Payer, E., & Cerwenka, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1440 · Cited by 378
Costa, L. A., Eiro, N., Fraile, M., Gonzalez, L. O., Saá, J., Garcia-Portabella, P., Vega, B., Schneider, J., & Vizoso, F. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03600-0 · Cited by 313
Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease
Lee, M., Lee, Y., Song, J., Lee, J., & Chang, S.-Y. (2018) · Immune Network · doi:10.4110/in.2018.18.e5 · Cited by 260
“Tumor can be attacked by a variety of immune cells such as CD8+ T cell, B cell, NK cell, and macrophage involving CX3CL1 (96).”
BackgroundHojo, S., Koizumi, K., Tsuneyama, K., Arita, Y., Cui, Z., Shinohara, K., Minami, T., Hashimoto, I., Nakayama, T., Sakurai, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3424 · Cited by 201
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Kremer, V., Ligtenberg, M. A., Zendehdel, R., Seitz, C., Duivenvoorden, A., Wennerberg, E., Colón, E., Scherman-Plogell, A.-H., & Lundqvist, A. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0275-9 · Cited by 178
“However, the RCC cells did not induce any detectable IFN-γ production (data not shown).”
BackgroundInfluential
Metadata
- Authors
- Xin, H., Kikuchi, T., Andarini, S., Ohkouchi, S., Suzuki, T., Nukiwa, T., Huqun, Hagiwara, K., Honjo, T., & Saijo, Y.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2005-04-22
- Volume
- 35
- Issue
- 5
- Pages
- 1371-1380
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2051998367
- Cited by
- 92
- References
- 5
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. https://app.cochat.ai/papers/10.1002/eji.200526042
- The paper
- Xin, H., Kikuchi, T., Andarini, S., Ohkouchi, S., Suzuki, T., Nukiwa, T., Huqun, Hagiwara, K., Honjo, T., & Saijo, Y. (2005). Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. European Journal of Immunology. https://doi.org/10.1002/eji.200526042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.